Literature DB >> 12163253

Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam.

Jeffrey Almond1, John Clemens, Howard Engers, Scott Halstead, Ha Ba Khiem, Ariel Pablos-Mendez, Yuri Pervikov, Tran Tan Tram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12163253     DOI： 10.1016/s0264-410x(02)00246-3

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Authors:  Joseph E Blaney; Jennifer M Matro; Brian R Murphy; Stephen S Whitehead
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.

Authors:  Joseph E Blaney; Christopher T Hanson; Kathryn A Hanley; Brian R Murphy; Stephen S Whitehead
Journal:  BMC Infect Dis       Date:  2004-10-04       Impact factor: 3.090

Review 3.  Economic impact of dengue fever in Latin America and the Caribbean: a systematic review.

Authors:  Andrés Laserna; Julián Barahona-Correa; Laura Baquero; Camilo Castañeda-Cardona; Diego Rosselli
Journal:  Rev Panam Salud Publica       Date:  2018-09-07

Review 4.  The Estimates of the Health and Economic Burden of Dengue in Vietnam.

Authors:  Trinh Manh Hung; Hannah E Clapham; Alison A Bettis; Hoang Quoc Cuong; Guy E Thwaites; Bridget A Wills; Maciej F Boni; Hugo C Turner
Journal:  Trends Parasitol       Date:  2018-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.